Reactive oxygen species (ROS) get a bad press, as evidenced by the notable trend in the use of dietary and cosmetic antioxidants. New work suggests, however, that ROS might have a role in mitigating certain cancers. See Letter p.106
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Vafa, O. et al. Mol. Cell 9, 1031–1044 (2002).
Irani, K. et al. Science 275, 1649–1652 (1997).
DeNicola, G. M. et al. Nature 475, 106–109 (2011).
Gao, P. et al. Cancer Cell 12, 230–238 (2007).
Gao, P. et al. Nature 458, 762–765 (2009).
Kensler, T. W., Wakabayashi, N. & Biswal, S. Annu. Rev. Pharmacol. Toxicol. 47, 89–116 (2007).
Hayes, J. D. & McMahon, M. Trends Biochem Sci. 34, 176–188 (2009).
Sablina, A. A. et al. Nature Med. 11, 1306–1313 (2005).
Yang, S. et al. Genes Dev. 25, 717–729 (2011).
Trachootham, D., Alexandre, J. & Huang, P. Nature Rev. Drug Discov. 8, 579–591 (2009).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Perera, R., Bardeesy, N. When antioxidants are bad. Nature 475, 43–44 (2011). https://doi.org/10.1038/475043a
Published:
Issue Date:
DOI: https://doi.org/10.1038/475043a